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background:  Oxidative stress affects clinical outcome in patients with ST-elevation acute coronary syndrome (STE-ACS). Although high-
density lipoprotein (HDL) particles are generally considered protective, deleterious properties of HDL have been observed in patients with 
acute myocardial infarction (AMI). Here, we assessed the impact of pro-oxidant HDL on all-cause mortality in STE-ACS patients.
methods:  We determined the antioxidant function of HDL in 247 prospectively enrolled patients undergoing primary PCI for STE-ACS. 
Patients were stratified as by a pro-oxidant serum HDL oxidant index (HOI≥1) or with an antioxidant serum HOI (HDL<1) capacity.
Results:  The median follow-up time was 23 months (IQR 14.-40). Pro-oxidant HDL was observed in 44% of STE-ACS patients and was 
independently associated with all-cause mortality with a hazard ratio of 3.30(95%CI 1.5-7.3, p = 0.003). Elevated neutrophil counts were 
a strong and independent predictor for pro-oxidant HDL with an odds ratio per standard deviation of 1.50(95%CI 1.1-2.0,p=0.008), as was 
history of prior AMI, elevated triglycerides levels and reduced glomerular filtration rate.
conclusion:  Pro-oxidant HDL represents a strong and independent predictor of long-term as well as short-term all-cause mortality in STE-
ACS patients. Elevated neutrophil counts predicted the presence of serum pro-oxidant HDL. The maintenance of HDL functions might be a 
promising therapeutic target in STE-ACS patients.
